Manfred Westphal Selected Research

zeta receptor

9/2006	RNA interference targeting protein tyrosine phosphatase zeta/receptor-type protein tyrosine phosphatase beta suppresses glioblastoma growth in vitro and in vivo.
12/2003	Expression and function of the receptor protein tyrosine phosphatase zeta and its ligand pleiotrophin in human astrocytomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Manfred Westphal Research Topics

Disease

75	Neoplasms (Cancer) 12/2022 - 01/2002
57	Glioblastoma (Glioblastoma Multiforme) 11/2022 - 01/2002
46	Glioma (Gliomas) 08/2022 - 01/2002
13	Brain Neoplasms (Brain Tumor) 10/2021 - 10/2003
6	Neoplasm Metastasis (Metastasis) 10/2021 - 07/2014
6	Astrocytoma (Pilocytic Astrocytoma) 08/2021 - 04/2003
6	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2021 - 08/2014
5	Meningioma (Meningiomas) 12/2022 - 03/2016
5	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2013
4	Ependymoma 08/2021 - 04/2005
4	Hemorrhage 01/2018 - 01/2014
3	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2022 - 04/2016
3	Seizures (Absence Seizure) 11/2022 - 01/2008
3	Pain (Aches) 05/2022 - 12/2009
3	Aneurysm (Aneurysms) 01/2022 - 01/2019
3	Hydrocephalus (Hydrocephaly) 01/2022 - 01/2018
3	Edema (Dropsy) 10/2021 - 12/2009
3	Infections 01/2021 - 01/2018
3	Circulating Neoplastic Cells 01/2019 - 07/2014
3	Necrosis 11/2018 - 08/2003
3	Residual Neoplasm 04/2017 - 02/2004
3	Disease Progression 01/2017 - 02/2004
2	Wounds and Injuries (Trauma) 12/2022 - 11/2015
2	Inflammation (Inflammations) 12/2022 - 12/2017
2	Headache Disorders (Headache Syndromes) 05/2022 - 12/2015
2	Epilepsy (Aura) 12/2021 - 06/2019
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2020 - 04/2016
2	Carcinoma (Carcinomatosis) 12/2017 - 01/2017
2	Hypoxia (Hypoxemia) 11/2013 - 07/2007
2	Breast Neoplasms (Breast Cancer) 07/2013 - 01/2002
2	Adenocarcinoma 01/2013 - 04/2010
2	Nervous System Diseases (Neurological Disorders) 12/2012 - 07/2010

Drug/Important Bio-Agent (IBA)

17	Biomarkers (Surrogate Marker)IBA 12/2022 - 12/2007
13	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 06/2010
12	Proteins (Proteins, Gene)FDA Link 12/2022 - 12/2003
10	ErbB Receptors (EGF Receptor)IBA 11/2017 - 07/2005
9	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021 - 12/2009
9	LigandsIBA 01/2017 - 10/2003
8	Temozolomide (Temodar)FDA LinkGeneric 01/2021 - 06/2011
6	EnzymesIBA 03/2020 - 02/2002
6	Pharmaceutical PreparationsIBA 10/2019 - 11/2004
6	epidermal growth factor receptor VIIIIBA 11/2017 - 09/2008
5	Epidermal Growth Factor (EGF)IBA 09/2017 - 06/2003
5	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2017 - 06/2003
5	Carmustine (FIVB)FDA Link 06/2011 - 01/2003
4	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2022 - 10/2003
4	MethyltransferasesIBA 01/2021 - 08/2011
4	Alkylating AgentsIBA 03/2020 - 09/2012
4	AntigensIBA 01/2018 - 04/2005
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2017 - 04/2003
4	poliferprosan 20 drug combination carmustine (Gliadel)FDA Link 01/2011 - 01/2003
4	Complementary DNA (cDNA)IBA 01/2008 - 10/2003
4	pleiotrophin (HARP)IBA 09/2006 - 06/2003
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2005 - 06/2003
3	Oxygen (Dioxygen)IBA 10/2022 - 04/2012
3	Bevacizumab (Avastin)FDA Link 03/2020 - 01/2017
3	Epithelial Cell Adhesion MoleculeIBA 01/2019 - 01/2017
3	nimotuzumabIBA 01/2018 - 12/2012
3	Tyrosine Kinase InhibitorsIBA 09/2017 - 10/2013
3	Monoclonal AntibodiesIBA 09/2017 - 07/2005
3	Indicators and Reagents (Reagents)IBA 01/2009 - 11/2004
3	Protein Tyrosine PhosphatasesIBA 09/2006 - 12/2003
3	Class 5 Receptor-Like Protein Tyrosine PhosphatasesIBA 09/2006 - 12/2003
2	Analgesics (Analgesic Drugs)IBA 05/2022 - 12/2009
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2022 - 11/2015
2	SteroidsIBA 10/2021 - 08/2018
2	TitaniumIBA 08/2021 - 01/2021
2	Nimodipine (Modus)FDA LinkGeneric 01/2021 - 05/2015
2	O-(6)-methylguanineIBA 01/2021 - 04/2017
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020 - 01/2018
2	ProdrugsIBA 10/2019 - 08/2013
2	Ganciclovir (Cytovene)FDA LinkGeneric 10/2019 - 08/2013
2	Thymidine KinaseIBA 10/2019 - 08/2013
2	Small Interfering RNA (siRNA)IBA 04/2019 - 09/2006
2	Peptides (Polypeptides)IBA 01/2018 - 05/2015
2	VaccinesIBA 01/2018 - 01/2018
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2017 - 02/2016
2	MicroRNAs (MicroRNA)IBA 12/2016 - 10/2015
2	AntibodiesIBA 02/2016 - 07/2014
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2016 - 10/2013
2	Insulin-Like PeptidesIBA 08/2015 - 06/2003
2	Glial Fibrillary Acidic ProteinIBA 07/2014 - 01/2006
2	O(6)-Methylguanine-DNA MethyltransferaseIBA 10/2013 - 12/2009
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 07/2013 - 10/2003
2	monoaminocarboxydihydroboraneIBA 01/2013 - 04/2010

Therapy/Procedure

34	Therapeutics 01/2022 - 01/2002
19	Drug Therapy (Chemotherapy) 08/2022 - 01/2003
11	Radiotherapy 08/2022 - 01/2005
9	Deep Brain Stimulation 12/2021 - 01/2009
7	Immunotherapy 10/2021 - 04/2010
6	Chemoradiotherapy 08/2021 - 01/2009
4	Decompressive Craniectomy 08/2021 - 04/2016
3	Craniotomy 05/2022 - 01/2016
3	Diskectomy (Discectomy) 06/2012 - 12/2006
3	Catheters 01/2011 - 08/2010
2	Decompression 09/2020 - 12/2009
2	Laminectomy 08/2017 - 12/2009
2	Vitrectomy 01/2015 - 08/2014
2	Injections 01/2014 - 10/2003
2	Electrodes (Electrode) 01/2013 - 01/2009